Ignite Creation Date:
2025-12-25 @ 2:15 AM
Ignite Modification Date:
2025-12-26 @ 12:44 AM
Study NCT ID:
NCT04496960
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-18
First Post:
2020-08-02
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren's Syndrome
Sponsor:
National Institute of Dental and Craniofacial Research (NIDCR)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-05-18
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-09-22
Completion Date Type:
ESTIMATED
First Submit Date:
2020-08-02
First Submit QC Date:
None
Study First Post Date:
2020-08-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-11-07
Results First Submit QC Date:
None
Results First Post Date:
2025-12-18
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-03
Last Update Post Date:
2025-12-18
Last Update Post Date Type:
ESTIMATED